Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

April 29, 2016 - 8:22 a.m.
European CHMP Adopts Positive Opinion for Gilead’s TAF-Based Single Tablet Regimen Odefsey® (Emtricitabine, Rilpivirine, Tenofovir Alafenamide) for Treatment of HIVPrinter Friendly Version 
April 28, 2016 - 4:04 p.m.
Gilead Sciences Announces Second Quarter 2016 DividendPrinter Friendly Version 

Upcoming Events

Tuesday, May 10, 2016 1:00 p.m. PT
Bank of America Merrill Lynch 2016 Healthcare Conference
LocationLas Vegas, NV
Wednesday, May 11, 2016 10:00 a.m. ET
Gilead Sciences 2016 Stockholders Meeting
LocationMillbrae, CA
Monday, May 23, 2016 9:30 a.m. ET
UBS Global Healthcare Conference
LocationNew York, NY
Friday, June 3, 2016 through Tuesday, June 7, 2016
American Society of Clinical Oncology (ASCO) 2016 Annual Meeting
LocationChicago, IL
Tuesday, June 7, 2016 through Friday, June 10, 2016
Gilead Sciences at Jefferies 2016 Healthcare Conference
LocationNew York, NY

Most Viewed Links

Updated 04/26/16
2.SEC Filings
3.Annual Reports
4.Stock Information
5.Fundamentals - Snapshot
* Data collected 04/18/16 - 04/25/16

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.